Novel hyaluronan formulation for preventing acute skin reactions in breast during radiotherapy: a randomized clinical trial

Purpose We conducted a randomized, double-blind, vehicle-controlled clinical trial to investigate the use of a new proprietary hyaluronan (HA) formulation for the prevention of acute skin toxicity in breast cancer patients undergoing radiotherapy (RT).